Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
NCT00652626
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
MDS
AML
Solid Tumors
Multiple Myeloma
Non-Hodgkin's Lymphoma
Hodgkin's Disease
Interventions
DRUG:
azacitidine
Sponsor
Celgene